Amedisys (AMED) PT Raised to $350 at RBC Capital
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 4 | New: 41
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 4 | New: 41
Join SI Premium – FREE
RBC Capital analyst Frank Morgan raised the price target on Amedisys (NASDAQ: AMED) to $350.00 (from $335.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Barclays Downgrades Unite Group (UTG:LN) to Underweight
- Eutelsat Communications SA (ETL:FP) (EUTLF) PT Lowered to EUR2.40 at Morgan Stanley
- Temple & Webster Group Ltd (TPW:AU) PT Lowered to AUD5.30 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
